Showing results (141-150 of 161) with videos related to
Sort By:
Pageof 17
Cephalalgia : an International Journal of Headache|May 13, 2022
Preclinical assessment of onabotulinumtoxinA for the treatment of mild traumatic brain injury-related acute and persistent post-traumatic headacheEdita Navratilova, Janice Oyarzo, Trent Anderson, et al.Aesthetic Surgery Journal|August 22, 2025
Longitudinal Computed Tomography Indicates No Negative Impact of OnabotulinumtoxinA on Mandibular Bone Density in a 12-Month, Double-Blind, Randomized, Repeat Treatment, Placebo-Controlled Study in Healthy Adults With Masseter Muscle ProminencePaul Kostenuik, Sanjay M Mallya, René Hopfinger, et al.The Journal of Biological Chemistry|October 17, 2002
Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neuronsPatrick G Foran, Nadiem Mohammed, Godfrey O Lisk, et al.The Journal of General Physiology|September 1, 2010
Arrangement of Kv1 alpha subunits dictates sensitivity to tetraethylammoniumAhmed Al-Sabi, Oleg Shamotienko, Sorcha Ni Dhochartaigh, et al.Amino Acids|January 20, 2010
Transglutaminase participates in the blockade of neurotransmitter release by tetanus toxin: evidence for a novel biological functionFrancesco Facchiano, Florence Deloye, Frédéric Doussau, et al.Journal of Medicinal Chemistry|February 23, 2017
A Rational Design of a Selective Inhibitor for Kv1.1 Channels Prevalent in Demyelinated Nerves That Improves Their Impaired Axonal ConductionAhmed Al-Sabi, Declan Daly, Patrick Hoefer, et al.Advances in Therapy|September 28, 2013
OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiologyDavid Ginsberg, Francisco Cruz, Sender Herschorn, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2010
Genetic evidence for an association of the TOR1A locus with segmental/focal dystoniaNutan Sharma, Ramon A Franco, John K Kuster, et al.Neurogenetics|May 21, 2003
A heteroplasmic mitochondrial complex I gene mutation in adult-onset dystoniaDavid K Simon, Jennifer Friedman, Xandra O Breakefield, et al.Aesthetic Surgery Journal|June 15, 2022
Safety, Pharmacodynamic Response, and Treatment Satisfaction With OnabotulinumtoxinA 40 U, 60 U, and 80 U in Subjects With Moderate to Severe Dynamic Glabellar LinesJohn H Joseph, Corey Maas, Melanie D Palm, et al.Pageof 17